• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CHEMISTRY ENZYMATIC CREATININE_2 REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CHEMISTRY ENZYMATIC CREATININE_2 REAGENTS Back to Search Results
Model Number ADVIA CHEMISTRY ENZYMATIC CREATININE_2 REAGENTS
Device Problem Insufficient Information (3190)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/09/2016
Event Type  malfunction  
Manufacturer Narrative
A siemens headquarters support center (hsc) specialist reviewed the data provided by the customer.The customer has informed hsc that this may be a sample specific issue, and that here have been no other discordants for the creatinine_2 assay on the advia chemistry system.The cause of the falsely elevated patient samples is unknown.
 
Event Description
The customer has obtained a falsely high result for the creatinine_2 assay on one patient sample on an advia chemistry 2400 instrument.The sample was run initially on (b)(6) 2016.A new sample draw was then run on an alternate platform and the result was lower.Another new sample draw was repeated on the same advia chemistry instrument on (b)(6) 2016 and the result was still higher than expected.The customer then decided to dilute the patient sample at 3 different dilution and the result was lower.The initial result was reported to the physician(s) and questioned.The result obtained on the alternate platform was also reported to the physician(s).There were no reports of patient intervention or adverse health consequences due to the high result on the patient sample for creatinine.
 
Manufacturer Narrative
Corrected information (10/26/2016): the reagent lot number for ecrea_2 and the udi number was listed incorrectly.This report has corrected information.In addition siemens headquarters support center (hsc) received feedback from a siemens customer service engineer (cse) at the site, regarding the ecrea_2 assay, whereas the use of the crea_2 jaffe assay may be more representative for the patient sample being tested.Siemens hsc has recommended based on this information provided by the cse that the customer use the crea_2 jaffe method, as there appears to be something in the patient sample interfering with the ecrea_2 result.The cause of the falsely elevated result on the patient sample is a possible interferant.
 
Manufacturer Narrative
The initial mdr 2432235-2016-00624 was filed on 10/18/2016.A siemens headquarters support center (hsc) specialist reviewed the data provided by the customer.The customer has informed hsc that this may be a sample specific issue, and that here have been no other discordants for the enzymatic creatinine_2 assay on the advia chemistry system.Additional information (10/20/2016): upon further review of the complaint it was noted by a siemens designated complaint handling (dcu) representative that the correct assay was enzymatic creatinine_2 and not creatinine_2.Based on this information, the following sections were updated to reflect the correction.
 
Event Description
The customer has obtained a falsely high result for the enzymatic creatinine_2 ( ecrea_2) assay on one patient sample on an advia chemistry 2400 instrument.The sample was run initially on (b)(6) 2016.A new sample draw was then run on an alternate platform and the result was lower.Another new sample draw was repeated on the same advia chemistry instrument on (b)(6) 2016 and the result was still higher than expected.The customer then decided to dilute the patient sample at 3 different dilution and the result was lower.The initial result was reported to the physician(s) and questioned.The result obtained on the alternate platform was also reported to the physician(s).There were no reports of patient intervention or adverse health consequences due to the high result on the patient sample for enzymatic creatinine_2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CHEMISTRY ENZYMATIC CREATININE_2 REAGENTS
Type of Device
ADVIA CHEMISTRY ENZYMATIC CREATININE_2 REAGENTS
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
SEKISUI DIAGNOSTICS PEI INC. (REG#8020316)
70 watts avenue
crumlin
charlottetown, pe c1e 2b9, BT29 4QY
CA   BT29 4QY
Manufacturer Contact
aarti aziz
511 benedict avenue
tarrytown, NY 10591
9145242683
MDR Report Key6036111
MDR Text Key57686112
Report Number2432235-2016-00624
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K070727
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 10/26/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model NumberADVIA CHEMISTRY ENZYMATIC CREATININE_2 REAGENTS
Device Catalogue Number10309050
Device Lot Number48352
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/28/2016
Initial Date FDA Received10/18/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received10/20/2016
10/26/2016
Was Device Evaluated by Manufacturer? No
Type of Device Usage Initial
Patient Sequence Number1
-
-